CC
BMY icon

Columbia Capital’s Bristol-Myers Squibb BMY Stock Holding History

Columbia Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$679K Sell
11,496
-36,443
-76% -$2.06M 0.74% 48
2014
Q3 		$2.45M Buy
+47,939
New +$2.39M 3.29% 14

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Columbia Capital's BMY Position: Q4 2014 in Review

Columbia Capital reduced its Bristol-Myers Squibb (BMY) stake by 76% in Q4 2014, selling an estimated $2.06M and leaving 11,496 shares worth $679K. The position accounts for 0.74% of the portfolio, ranked #48.

Columbia Capital first reported a position in BMY in Q3 2014 and has held it in 2 quarters since. The position peaked at $2.45M in Q3 2014. 1,411 funds tracked by Wall St. Rank hold BMY as of Q4 2014.

  • Columbia Capital held 11,496 shares of Bristol-Myers Squibb worth $679K as of Q4 2014.
  • Columbia Capital sold 36,443 Bristol-Myers Squibb shares in Q4 2014, an estimated $2.06M.
  • Bristol-Myers Squibb made up 0.74% of Columbia Capital's portfolio in Q4 2014, its #48 holding.
  • Columbia Capital first reported a position in Bristol-Myers Squibb in Q3 2014 and has held it in 2 quarters since.
  • Columbia Capital's Bristol-Myers Squibb position peaked at $2.45M in Q3 2014.
  • 1,411 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2014.

Based on Columbia Capital's 13F filing for Q4 2014, filed 11 Feb 2015.